How I treat unexplained refractory iron deficiency anemia

Slides:



Advertisements
Similar presentations
Role of iron deficiency anemia in the propagation of beta thalassemia gene Usman, M., Moinuddin, M., Ahmed, S.A. (2011) Korean J Hematol 46: Microcytic.
Advertisements

Iron Deficiency Anemia General Medicine Conference August 11, 2008.
Iron Deficiency: Clinical Sequelae and Diagnosis
Laboratory Data in Nutrition Assessment Chapter 18.
Iron Deficiency Anemia Diagnostic Tests. Complete Blood Count (CBC): Hemoglobin – Males (< 13.5 g/dL), Females (< 12 g/dL) Hematocrit – Males (< 41%),
Nada Mohamed Ahmed, MD, MT (ASCP)i. Definition. Physiology of iron. Causes of iron deficiency. At risk group. Stages of IDA (pathophysiology). Symptoms.
Iron Deficiency Anemia Iron Metabolism: Iron Metabolism: IRON INTAKE (Dietary) - “ average ” adult diet = mg Fe/day - absorption = 5-10% (0.5-2 mg/day)
Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,
Clinical spectrum and severity of hemolytic anemia in glucose 6-phosphate dehydrogenase–deficient children receiving dapsone by Allan Pamba, Naomi D. Richardson,
Reticulocyte Hb equivalent and hypochromic red cells in the study of erythropoiesis in pregnancy Eloísa Urrechaga 1, Elia Crespo 1, Luís Borque 2, Jesús.
Determination of acute lung injury after repeated platelet transfusions by Laurence Corash, Jin Sying Lin, Claire D. Sherman, and Joseph Eiden Blood Volume.
Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis  Riccardo Marmo, MD, Gianluca Rotondano, MD, Maria.
Assessment of nutritional and micronutrient status Wolfgang Stütz Institute of Biological Chemistry and Nutrition University of Hohenheim Scale-N Kickoff-Meeting,
Specificity 79.0 % (95 % CI %) at the threshold value 9.6
Iron Deficiency Anaemia
Diagnostic yield of small-bowel capsule endoscopy in patients with iron-deficiency anemia: a systematic review  Anastasios Koulaouzidis, MD, MRCP, Emanuele.
Iron Metabolism and Anemia
HEMATOLGY Hemoglobin:
The influence of high-altitude living on body iron
CPR 1.1. Identifying Patients and Initiating Evaluation
VEGF therapy: risky business for established plaques?
by James O. Armitage, and Dan L. Longo
Knocking out the PCFT by Donald W. Jacobsen Blood
Utility of factor X concentrate for the treatment of acquired factor X deficiency in systemic light-chain amyloidosis by Shameem Mahmood, Julie Blundell,
How I treat autoimmune hemolytic anemias in adults
A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.
How I treat elderly patients with myeloma
Use of Erythropoiesis-Stimulating Agents in Patients With Anemia of Chronic Kidney Disease: Overcoming the Pharmacological and Pharmacoeconomic Limitations.
How to Treat MDS without Stem Cell Transplantation
SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness by Jeffrey.
American Journal of Kidney Diseases 
A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease by Sten Myrehaug, Melania Pintilie, Lingsong.
Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children by Ayami Yoshimi, Charlotte.
Hemoglobin levels in African-Americans
معاونت امور بهداشتي دانشگاه علوم پزشكي شهيد صدوقي يزد
Volume 118, Issue 1, Pages (January 2000)
Control of iron deficiency anemia in low- and middle-income countries
Successful Treatment of Iron Overload by Phlebotomies in a Patient With Severe Congenital Dyserythropoietic Anemia Type II by W.K. Hofmann, J.P. Kaltwasser,
Relationship between hepatocellular injury and transfusional iron overload prior to and during iron chelation with desferrioxamine: a study in adult patients.
by James D. Cook, Carol H. Flowers, and Barry S. Skikne
by Sabah Sallah, and Jim Y. Wan
Blocking VWF platelet binding to treat TTP
by Jon E. Arnason, Federico Campigotto, Donna Neuberg, and James B
How I treat refractory CLL
Anemia Rachel McNair.
Volume 56, Issue 3, Pages (September 1999)
Overcoming barriers that inhibit proper treatment of anemia
How I treat cancer-associated venous thromboembolism
FIGURE 1 Distribution of total body iron (calculated from serum ferritin and soluble transferrin receptor ... FIGURE 1 Distribution of total body iron.
Beta thalasemia.
Volume 60, Issue 6, Pages (December 2001)
660. Bowel/Bladder Sensation and Control in Patients with Spinal Cord Injury Treated with Human Embryonic Stem Cell Therapy  Geeta Shroff  Molecular Therapy 
Volume 68, Issue 6, Pages (December 2005)
Outcome of endoscopic treatment for peptic ulcer bleeding: Is a second look necessary? A meta-analysis  Riccardo Marmo, MD, Gianluca Rotondano, MD, Maria.
Approach to anemia.
Volume 63, Issue 3, Pages (March 2003)
by Wendy Lim, Sara K. Vesely, and James N. George
Overcoming “aspirin resistance” in MPN
Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation  A.K. Singh, D.W. Coyne,
FIGURE 1 Study population. EVD, Ebola virus disease.
Treatment versus Transplant for Challenging Hematologic Disorders
How I treat thrombocytopenia in pregnancy
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
Determinants of iron deficiency anemia.
Adjusted HRs for type 2 diabetes by ferritin, TSAT, serum iron and transferrin levels in men and women. Adjusted HRs for type 2 diabetes by ferritin, TSAT,
How I treat heparin-induced thrombocytopenia and thrombosis
How I treat acquired aplastic anemia
by Lapo Alinari, and Kristie A. Blum
Initial treatment of CLL: integrating biology and functional status
Presentation transcript:

How I treat unexplained refractory iron deficiency anemia by Chaim Hershko, and Clara Camaschella Blood Volume 123(3):326-333 January 16, 2014 ©2014 by American Society of Hematology

Diagnostic workup preceding the recognition of unexplained refractory IDA. Diagnostic workup preceding the recognition of subjects with unexplained refractory IDA: in men and postmenopausal women detailed gastrointestinal studies are mandatory. Diagnostic workup preceding the recognition of unexplained refractory IDA. Diagnostic workup preceding the recognition of subjects with unexplained refractory IDA: in men and postmenopausal women detailed gastrointestinal studies are mandatory. By contrast, in patients with increased physiological needs and in the majority of low-risk patients such as women of child-bearing age, endoscopic gastrointestinal studies preceding oral iron treatment are rarely necessary. The limitations of this diagnostic approach are that (1) complete gastrointestinal workup fails to identify the cause of IDA in a substantial proportion of subjects and (2) such patients, and patients in whom IDA was assumed to be physiological, may be refractory to oral iron therapy. CHr, reticulocyte Hb content; sTfR, soluble transferrin receptor; Tf, transferrin; ZPP, zinc protoporphyrin. Chaim Hershko, and Clara Camaschella Blood 2014;123:326-333 ©2014 by American Society of Hematology